Related references
Note: Only part of the references are listed.Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastomas
Janice K. Laramy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Characterization of In Vivo Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance
Kristina B. Emdal et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Simultaneous two-color stimulated Raman scattering microscopy by adding a fiber amplifier to a 2 ps OPO-based SRS microscope
Wenlong Yang et al.
OPTICS LETTERS (2017)
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
Joerg Felsberg et al.
CLINICAL CANCER RESEARCH (2017)
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients
J. J. Raizer et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Label-Free Neurosurgical Pathology with Stimulated Raman Imaging
Fa-Ke Lu et al.
CANCER RESEARCH (2016)
Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas
Margaret Folaron et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Early signaling dynamics of the epidermal growth factor receptor
Raven J. Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Phosphotyrosine Signaling Analysis in Human Tumors Is Confounded by Systemic Ischemia-Driven Artifacts and Intra-Specimen Heterogeneity
Aaron S. Gajadhar et al.
CANCER RESEARCH (2015)
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment
O. van Tellingen et al.
DRUG RESISTANCE UPDATES (2015)
Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+T Cell Responses
Danielle N. Renner et al.
PLOS ONE (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
Automatic Generic Registration of Mass Spectrometry Imaging Data to Histology Using Nonlinear Stochastic Embedding
Walid M. Abdelmoula et al.
ANALYTICAL CHEMISTRY (2014)
Quantitative Analysis of Signaling Networks across Differentially Embedded Tumors Highlights Interpatient Heterogeneity in Human Glioblastoma
Hannah Johnson et al.
JOURNAL OF PROTEOME RESEARCH (2014)
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma
Jennifer L. Clarke et al.
NEURO-ONCOLOGY (2014)
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2014)
Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas
Anne L. Baldock et al.
PLOS ONE (2014)
A Mimetic Tissue Model for the Quantification of Drug Distributions by MALDI Imaging Mass Spectrometry
M. Reid Groseclose et al.
ANALYTICAL CHEMISTRY (2013)
p190A RhoGAP is involved in EGFR pathways and promotes proliferation, invasion and migration in lung adenocarcinoma cells
Hirotsugu Notsuda et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Function of the Blood-Brain Barrier and Restriction of Drug Delivery to Invasive Glioma Cells: Findings in an Orthotopic Rat Xenograft Model of Glioma
Sagar Agarwal et al.
DRUG METABOLISM AND DISPOSITION (2013)
Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP
Nienke A. de Vries et al.
INVESTIGATIONAL NEW DRUGS (2012)
The 4G10, pY20 and p-TYR-100 antibody specificity: profiling by peptide microarrays
Michele Tinti et al.
NEW BIOTECHNOLOGY (2012)
Cytoscape 2.8: new features for data integration and network visualization
Michael E. Smoot et al.
BIOINFORMATICS (2011)
Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical Model
Christina H. Wang et al.
CANCER RESEARCH (2009)
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Michael D. Prados et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
Serena Marchetti et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: Establishing a treatment paradigm
Elizabeth R. Gerstner et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The blood-brain barrier and cancer:: Transporters, treatment, and Trojan horses
John F. Deeken et al.
CLINICAL CANCER RESEARCH (2007)
Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2007)
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response
JN Sarkaria et al.
CLINICAL CANCER RESEARCH (2006)
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma
MD Prados et al.
NEURO-ONCOLOGY (2006)
FDA drug approval summary:: Erlotinib (Tarceva®) tablets
MH Cohen et al.
ONCOLOGIST (2005)
Virtual and real brain tumors: using mathematical modeling' to quantify glioma growth and invasion
KR Swanson et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Factors influencing survival in high-grade gliomas
JC Buckner
SEMINARS IN ONCOLOGY (2003)
Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy
KR Swanson et al.
BRITISH JOURNAL OF CANCER (2002)
Malignant glioma: genetics and biology of a grave matter
EA Maher et al.
GENES & DEVELOPMENT (2001)
Share Paper
